跳至主要内容
临床试验/ACTRN12613000754741
ACTRN12613000754741终止3 期

The ASPREE-Knee Sub-study: Does aspirin slow the progression of knee structural damage in adults over 70 years of age?

Monash University0 个研究点目标入组 165 人开始时间: 2013年7月5日最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
165

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
70 Years 至 o limit(—)
性别
All

入选标准

  • Randomised ASPREE participants in Melbourne (Age >=70 years, free of previous cardiovascular disease or stroke, have preserved intellectual function and have no known life-limiting illness)
  • Aged 70 and over
  • Able and willing to provide informed consent

排除标准

  • 1)As for ASPREE (Cardiovascular disease, impaired intellectual function, life limiting illness);
  • 2)People with planned or prior knee joint replacement surgery of the dominant knee; unable to walk independently (no stick or frame).
  • 3)People with rheumatoid arthritis, other inflammatory arthritis, or significant knee injury;
  • 4)People undergoing arthroscopy or open surgery in the index knee in the last 12 months;
  • 5)People receiving intra-articular therapy in the index knee in the last 12 months;
  • 6)Any contraindication to MRI scanning (e.g. implanted pacemaker, metal sutures, presence of shrapnel or iron filings in the eye, or claustrophobia).

研究者

相似试验

The ASPREE-Knee Sub-study: Does aspirin slow the... | 临床试验